As implementation of the US Food and Drug Administration's (FDA) final rule on laboratory-developed tests (LDTs) continues amidst legal challenges from several industry stakeholders, efforts are also afoot to revive legislative approaches to LDT regulation and diagnostics reform.
For the full article click here: New Organization Pushing for Law on LDT Regulation as Congress Revisits Legislative Efforts